Eri Tabuchi

Title: Eri Tabuchi: Innovator in Biochemical Engineering

Introduction

Eri Tabuchi is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of biochemical engineering, particularly in the development of innovative methods for producing valuable compounds.

Latest Patents

Eri Tabuchi holds 2 patents that showcase his expertise. His latest patents include a mutant glutamate-cysteine ligase and a method for manufacturing gamma glutamyl-valyl-glycine. This invention provides a mutant glutamate-cysteine ligase (GSHA) suitable for generating γ-Glu-Val, along with a method for producing γ-Glu-Val-Gly using the same. The production of γ-Glu-Val involves utilizing a mutant GSHA with a specific mutation, employing Glu and Val as raw materials. Furthermore, γ-Glu-Val-Gly is produced by using γ-Glu-Val and Gly as raw materials, with the same mutant GSHA. Another significant patent involves a method for producing monatin using an L-amino acid aminotransferase, which improves the yield of 2R,4R-Monatin.

Career Highlights

Eri Tabuchi is currently associated with Ajinomoto Co., Ltd., a leading company in the food and biotechnology sectors. His work focuses on enhancing production methods for various biochemical compounds, contributing to advancements in the industry.

Collaborations

Eri collaborates with talented coworkers, including Uno Tagami and Ayako Sasahara, who contribute to his innovative projects and research endeavors.

Conclusion

Eri Tabuchi's contributions to biochemical engineering through his patents and work at Ajinomoto Co., Ltd. highlight his role as a key innovator in the field. His advancements in production methods are paving the way for future developments in biotechnology.